Article Type
Changed
Fri, 12/07/2018 - 07:23
Display Headline
Treatment of giant-cell arteritis: Where we have been and why we must move on
Article PDF
Author and Disclosure Information

Gary S. Hoffman, MD
Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH

Correspondence: Gary S. Hoffman, MD, Harold C. Schott Chair of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, A50, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Publications
Page Number
SII117-SII120
Author and Disclosure Information

Gary S. Hoffman, MD
Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH

Correspondence: Gary S. Hoffman, MD, Harold C. Schott Chair of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, A50, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Gary S. Hoffman, MD
Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH

Correspondence: Gary S. Hoffman, MD, Harold C. Schott Chair of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, A50, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Page Number
SII117-SII120
Page Number
SII117-SII120
Publications
Publications
Article Type
Display Headline
Treatment of giant-cell arteritis: Where we have been and why we must move on
Display Headline
Treatment of giant-cell arteritis: Where we have been and why we must move on
Citation Override
Cleveland Clinic Journal of Medicine 2002 April;69(suppl 2):SII117-SII120
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media